Analysis of Genotoxic impurities

Significance of the Topic

Genotoxic impurities in pharmaceutical products can induce mutations and compromise patient safety. Regulatory agencies mandate rigorous detection of trace level alkyl halides to ensure drug quality and compliance.

Objectives and Study Overview

This application note demonstrates a robust GCMS procedure for simultaneous analysis of six volatile genotoxic alkyl halides at low microgram per milliliter levels in DMSO. The focus is on method performance for routine quality control in pharmaceutical laboratories.

Methodology and Instrumentation

A capillary GCMS system equipped with a 20 meter SH I 624Sil MS column with 0.18 millimeter inner diameter and 1 micrometer film was employed. Key parameters included:

• Oven temperature program from 40°C hold to 200°C at 20°C per minute
• Splitless injection of 1 microliter with a 0.5 minute purge delay
• Helium carrier gas at constant flow achieving 40 centimeter per second linear velocity
• Electron ionization mass spectrometry with source at 280°C, scan range 30 to 300 amu, five scans per second
• Monitored ions at m/z values 42, 43, 57 and 108 for target analytes

Main Results and Discussion

All six target compounds showed baseline separation within the defined temperature program. The method achieved reproducible retention times and adequate sensitivity for quantitation at 1 microgram per milliliter. Signal to noise ratios exceeded validation criteria and no significant carry over was observed.

Benefits and Practical Applications

This approach provides pharmaceutical analysts with a fast and reliable protocol for trace level screening of genotoxic impurities. It supports compliance with ICH guidelines and can be integrated into QA QC workflows for raw materials and final formulations.

Future Trends and Potential Applications

Advances in high resolution mass spectrometry could further improve selectivity and lower detection limits. Miniaturized capillary columns and rapid temperature programming offer potential for faster throughput. Integration with automated sample preparation will enhance routine impurity profiling.

Conclusion

The described GCMS method delivers sensitive, accurate, and reproducible analysis of key genotoxic alkyl halides in pharmaceutical matrices. Its implementation strengthens impurity control strategies and ensures patient safety.

References

• Shimadzu Corporation Application Note ERAS 1000 0491 First Edition Sep 2023